Aura Biosciences (AURA) News Today $6.28 -0.03 (-0.40%) As of 12:35 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Aura Biosciences Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Aura Biosciences (NASDAQ:AURA) Stock Jumps 3.6% - Still a Buy?October 7, 2026 | marketbeat.comAura Biosciences, Inc.(NasdaqGM:AURA) added to S&P Biotechnology Select Industry IndexSeptember 21, 2026 | marketscreener.comMAura Biosciences, Inc. (AURA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeptember 16, 2026 | seekingalpha.comAura Biosciences to Participate in Upcoming Investor ConferenceSeptember 2, 2026 | globenewswire.comAura Biosciences Grants Inducement Equity Awards to Newly Appointed ExecutivesSeptember 1, 2026 | quiverquant.comQAura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)September 1, 2026 | globenewswire.comAnalysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Corbus Pharmaceuticals (CRBP)August 13, 2026 | theglobeandmail.comAura Biosciences: Ocular Oncology Firm Under New Management Has Shot At ApprovalAugust 12, 2026 | seekingalpha.comAura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business HighlightsAugust 11, 2026 | markets.businessinsider.comAura Biosciences Expands Authorized Shares and Incentive PlanAugust 5, 2026 | tipranks.comAura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of DirectorsJuly 8, 2026 | globenewswire.comAura Biosciences, Inc. ($AURA) Former President, CEO and Director 2025 Pay RevealedJune 30, 2026 | quiverquant.comQAura Biosciences (NASDAQ:AURA) Insider Anthony Gibney Sells 12,824 SharesJune 17, 2026 | insidertrades.comAura Biosciences Announces Results of 2026 Annual MeetingJune 11, 2026 | tipranks.comAura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal MelanomaJune 1, 2026 | globenewswire.comAura Biosciences Grants Inducement Equity Awards to New CEO Natalie HollesMay 19, 2026 | quiverquant.comQAura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)May 19, 2026 | globenewswire.comAura Biosciences Inc (AURA) Gets a Buy from LifeSci CapitalMay 17, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN) and Aura Biosciences Inc (AURA)May 14, 2026 | theglobeandmail.comAura Biosciences to Participate in Upcoming Investor ConferencesMay 12, 2026 | globenewswire.comMatrix Capital Management Comp Sells 6,922,870 Shares of Aura Biosciences (NASDAQ:AURA) StockMay 12, 2026 | insidertrades.comAura Biosciences Reports First Quarter 2026 Financial Results and Business HighlightsMay 11, 2026 | globenewswire.comAura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional SharesMay 5, 2026 | markets.businessinsider.comAura Biosciences Closes $299.4 Million Public Offering to Advance Precision Therapies for Solid TumorsMay 5, 2026 | quiverquant.comQAura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional SharesMay 5, 2026 | globenewswire.comNorwegian Cruise Line, Aura Biosciences and other big stocks moving lower in Monday's pre-market sessionMay 4, 2026 | msn.comAura Biosciences Names Natalie Holles as Chief ExecutiveMay 4, 2026 | marketwatch.comAura Biosciences Stock Climbs on CEO Appointment, Drug Trial Enrollment ProgressMay 4, 2026 | marketwatch.comAura Biosciences Inc. Announces Pricing of $260.3 Million Public Offering of Common Stock and Pre-Funded WarrantsMay 4, 2026 | quiverquant.comQAura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded WarrantsMay 4, 2026 | globenewswire.comAura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsMay 4, 2026 | globenewswire.comAura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment CompletionMay 4, 2026 | globenewswire.comAura Biosciences, Inc. (AURA) Stock Price, News, Quote & History - Yahoo FinanceApril 29, 2026 | finance.yahoo.comAura Biosciences (NASDAQ:AURA) Insider Sells $82,400.76 in StockApril 17, 2026 | insidertrades.comAura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business HighlightsMarch 30, 2026 | globenewswire.comAura Biosciences (NASDAQ:AURA) SVP Amy Elazzouzi Sells 8,549 SharesFebruary 18, 2026 | insidertrades.comWe're Keeping An Eye On Aura Biosciences' (NASDAQ:AURA) Cash Burn RateJanuary 22, 2026 | finance.yahoo.comAura Biosciences (NASDAQ:AURA) Insider Sells $82,270.08 in StockJanuary 21, 2026 | insidertrades.comTRIMTECH Therapeutics appoints Alison Lawton as Chair of the BoardDecember 4, 2025 | msn.comEvercore ISI Group Reiterates Aura Biosciences (AURA) Outperform RecommendationNovember 27, 2025 | msn.comAura Biosciences re-initiated with an Outperform at Evercore ISINovember 25, 2025 | msn.comAura Biosciences to Participate in the 8th Annual Evercore Healthcare ConferenceNovember 24, 2025 | globenewswire.comAura Biosciences: Bringing Not-Quite-Viruses Closer To Fruition In CancerNovember 15, 2025 | seekingalpha.comAura Biosciences Provides Phase 3 CoMpass Trial Update: Enrollment Completion Expected in 2026 with Topline Data by Q4 2027, Highlighting Bel-sar's Potential in Bladder Cancer TreatmentsNovember 13, 2025 | quiverquant.comQAura Biosciences Reports Third Quarter 2025 Financial Results and Business HighlightsNovember 13, 2025 | globenewswire.comAura Biosciences (NASDAQ:AURA) Insider Sells $57,461.15 in StockOctober 30, 2025 | insidertrades.comAura Biosciences (NASDAQ:AURA) CTO Mark Plavsic Sells 12,169 SharesOctober 17, 2025 | insidertrades.comAura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 3, 2025 | globenewswire.comUveal Melanoma Market Analysis Across the 7MM: Key Insights and Outlook Through 2034 | DelveInsightAugust 21, 2025 | finance.yahoo.comInsider Selling: Aura Biosciences, Inc. (NASDAQ:AURA) SVP Sells 7,722 Shares of StockAugust 19, 2025 | insidertrades.com Aura Biosciences Media Mentions By Week Aura Biosciences Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AURA News Sentiment▼1.820.69▲Average Healthcare News Sentiment Aura Biosciences News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AURA Articles This Week▼13▲AURA Articles Average Week Aura Biosciences Trends on MarketBeatThis week vs. last weekNew Followers1Searches2+100%Page Views1,611-12% Get Aura Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Beam Therapeutics News Today NewAmsterdam Pharma News Today Viridian Therapeutics News Today ADMA Biologics News Today Precigen News Today SELLAS Life Sciences Group News Today Celldex Therapeutics News Today Aurinia Pharmaceuticals News Today Agios Pharmaceuticals News Today Vera Therapeutics News Today News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Aura Biosciences dated 10/7/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredThe chip inside every TeslaEvery Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aura Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aura Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
